NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373 | -16.9% | 8,437 | -8.6% | 0.03% | -22.2% |
| Q2 2023 | $449 | +13.4% | 9,232 | +29.4% | 0.04% | +24.1% |
| Q1 2023 | $396 | -11.0% | 7,135 | -35.6% | 0.03% | -21.6% |
| Q4 2022 | $445 | -99.9% | 11,083 | +23.1% | 0.04% | 0.0% |
| Q3 2022 | $394,000 | -13.2% | 9,002 | -29.7% | 0.04% | -9.8% |
| Q2 2022 | $454,000 | +62.1% | 12,803 | +86.0% | 0.04% | +355.6% |
| Q1 2022 | $280,000 | – | 6,882 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |